Michael Amoroso Precision Biosciences Inc (DTIL) insider trading activity

Michael Amoroso is President and CEO of PRECISION BIOSCIENCES INC. Currently has a direct ownership of 196,154 shares of DTIL, which is worth approximately $1.16 Million. The most recent transaction as insider was on Jan 22, 2026, when has been sold 34,799 shares (Common Stock) at a price of $4.17 per share, resulting in proceeds of $145,111. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 196K

79.07% 3M change

83.17% 12M change

Total Value Held $1.16 Million

Michael Amoroso Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 22 2026	SELL Open market or private sale	$145,111 $4.17 p/Share	34,799 Reduced 15.07%	196,154 Common Stock
Jan 20 2026	BUY Exercise of conversion of derivative security	-	115,378 Added 33.31%	230,953 Common Stock
Nov 03 2025	SELL Open market or private sale	$22,124 $6.49 p/Share	3,409 Reduced 2.87%	115,575 Common Stock
Nov 02 2025	BUY Exercise of conversion of derivative security	-	9,444 Added 7.35%	118,984 Common Stock
Mar 24 2025	SELL Open market or private sale	$5,359 $5.56 p/Share	964 Reduced 0.87%	109,540 Common Stock
Mar 21 2025	BUY Exercise of conversion of derivative security	-	3,417 Added 3.0%	110,504 Common Stock
Jan 21 2025	SELL Open market or private sale	$172,033 $4.67 p/Share	36,838 Reduced 25.6%	107,087 Common Stock

Jan 20 2025	BUY Exercise of conversion of derivative security	-	115,388 Added 44.5%	143,925 Common Stock
Nov 04 2024	SELL Open market or private sale	$24,668 $8.19 p/Share	3,012 Reduced 9.55%	28,537 Common Stock
Nov 02 2024	BUY Exercise of conversion of derivative security	-	9,443 Added 23.04%	31,549 Common Stock
May 08 2024	BUY Grant, award, or other acquisition	$100,008 $12.0 p/Share	8,334 Added 27.38%	22,106 Common Stock
May 02 2024	SELL Open market or private sale	$15,748 $10.32 p/Share	1,526 Reduced 9.98%	13,772 Common Stock
May 01 2024	BUY Exercise of conversion of derivative security	-	3,417 Added 18.26%	15,298 Common Stock
Jan 22 2024	SELL Open market or private sale	$49,460 $0.36 p/Share	137,390 Reduced 27.82%	356,433 Common Stock
Jan 20 2024	BUY Exercise of conversion of derivative security	-	266,720 Added 35.07%	493,823 Common Stock
Nov 03 2023	SELL Open market or private sale	$50,010 $0.4 p/Share	125,025 Reduced 35.51%	227,103 Common Stock
Nov 02 2023	BUY Exercise of conversion of derivative security	-	283,390 Added 44.59%	352,128 Common Stock
Mar 22 2023	SELL Open market or private sale	$38,539 $0.82 p/Share	46,999 Reduced 40.61%	68,738 Common Stock
Mar 21 2023	BUY Exercise of conversion of derivative security	-	102,535 Added 46.98%	115,737 Common Stock
Oct 17 2022	SELL Open market or private sale	$14,528 $1.32 p/Share	11,006 Reduced 45.46%	13,202 Common Stock
Oct 15 2022	BUY Exercise of conversion of derivative security	-	24,208 Added 50.0%	24,208 Common Stock

Also insider at

ABEO

ABEONA THERAPEUTICS INC. Healthcare

Director

Michael Amoroso

President and CEO

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DTIL shares.

Notify only if

Value

Insider Trading

Get notified when an Precision Biosciences Inc insider buys or sells DTIL shares.

Notify only if

Operation

Value

Type

News

Receive news related to PRECISION BIOSCIENCES INC

Track Activities on DTIL

Account